Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Clinical guidelines recommend chromosomal microarray analysis (CMA) for all children with autism spectrum disorders (ASDs). We explored the test’s perceived usefulness among parents of children with ASD who had undergone CMA, and received a result categorized as pathogenic, variant of uncertain significance, or negative. Fifty-seven parents participated in a semi-structured telephone interview, and 50 also completed a survey. Most parents reported that CMA was helpful for their child and family. Major themes regarding perceived usefulness were: medical care, educational and behavioral interventions, causal explanation, information for family members, and advancing knowledge. Limits to utility, uncertainties and negative outcomes were also identified. Our findings highlight the importance of considering both health and non-health related utility in genomic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., Church, D. M., Crolla, J. A., Eichler, E. E., Epstein, C. J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.006 · Cited by 2,882 · cited 4×
“Studies with parents of children with ASD have reported that contributing to genetic research can be a powerful motivator for testing (Chen et al. 2013; Miller et al. 2010; Trottier et al. 2013), and can provide a sense of control and hope (Trottier et al.”
InfluentialSelf-citationDawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., Donaldson, A., & Varley, J. (2010) · Pediatrics · doi:10.1542/peds.2009-0958 · Cited by 2,835 · cited 1×
“…prognosis, tailor the care of affected individuals, shorten the ‘diagnostic odyssey,’ and facilitate access to appropriate early interventions (Dawson et al. 2010; Eriksson et al. 2013; Hayward et al. 2009; Heil and Schaaf 2013; Lintas and Persico 2009; Narcisa et al. 2012; Reiff and…”
BackgroundKearney, H. M., Thorland, E. C., Brown, K. K., Quintero-Rivera, F., & South, S. T. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182217a3a · Cited by 929
A Systematic Review of Early Intensive Intervention for Autism Spectrum Disorders
Warren, Z., McPheeters, M. L., Sathe, N., Foss-Feig, J. H., Glasser, A., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0426 · Cited by 790
Schaefer, G. B., & Mendelsohn, N. J. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.32 · Cited by 537 · cited 4×
“A reporting scheme is now used in some laboratories that differentiates between VUS results that are “VUS,” “VUS—likely pathogenic” and “VUS—likely benign” (Green et al. 2013; Kearney et al. 2011; Schaefer and Mendelsohn 2013).”
InfluentialGenomics, Intellectual Disability, and Autism
Mefford, H. C., Batshaw, M. L., & Hoffman, E. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114194 · Cited by 329 · cited 4×
“…however, does not identify balanced chromosomal rearrangements, single nucleotide changes associated with many genetic conditions, or copy number alterations smaller than the resolution of those detected by the technology in use (Battaglia et al. 2013; Mefford et al. 2012; Roberts et al. 2014).”
InfluentialIn search of biomarkers for autism: scientific, social and ethical challenges
Walsh, P., Elsabbagh, M., Bolton, P., & Singh, I. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3113 · Cited by 249
Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist
Lintas, C., & Persico, A. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060871 · Cited by 178
Selkirk, C. G., McCarthy Veach, P., Lian, F., Schimmenti, L., & LeRoy, B. S. (2009) · Journal of Genetic Counseling · doi:10.1007/s10897-009-9233-0 · Cited by 118
Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000002 · Cited by 72
Research works printed but not linked: 57
- Ali-Khan, S. E., Daar, A. S., Shuman, C., Ray, P. N., & Scherer, S. W. (2009). Whole genome scanning: Resolving clinical diagnosis and management amidst complex data. Pediatric Research, 66(4), 357–363. · DOI
- Battaglia, A., Doccini, V., Bernardini, L., Novelli, A., Loddo, S., Capalbo, A., & Carey, J. C. (2013). Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. European Journal of Paediatric Neurology, 17(6), 589–599. · DOI · Paper page
- Bazeley, P. (2007). Qualitative analysis with Nvivo. Thousand Oaks, CA: Sage Publications Ltd.
- Beaudet, A. L. (2013). The utility of chromosomal microarray analysis in developmental and behavioral pediatrics. Child Development, 84(1), 121–132. · DOI
- Bernard, H. R. (2013). Social research methods: Qualitative and quantitative approaches. Thousand Oaks, CA: Sage Publications.
- Biesecker, B. B., & Erby, L. (2008). Adaptation to living with a genetic condition or risk: A mini-review. Clinical Genetics, 74(5), 401–407. doi: 10.1111/j.1399-0004.2008.01088.x . · DOI
- Bradbury, A. R., Patrick-Miller, L., & Domchek, S. (2014). Multiplex genetic testing: Reconsidering utility and informed consent in the era of next-generation sequencing. Genetics in Medicine, 17, 97–98. · DOI
- Burke, W., Laberge, A. M., & Press, N. (2010). Debating clinical utility. Public Health Genomics, 13(4), 215–223. doi: 10.1159/000279623 . · DOI
- Carter, M., & Scherer, S. (2013). Autism spectrum disorder in the genetics clinic: A review. Clinical Genetics, 83(5), 399–407. · DOI · Paper page
- Chao, S., Roberts, J. S., Marteau, T. M., Silliman, R., Cupples, L. A., & Green, R. C. (2008). Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL study. Alzheimer Disease and Associated Disorders, 22(1), 94–97. doi: 10.1097/WAD.0b013e31815a9dcc . · DOI · Paper page
- Chen, L., Xu, L., Huang, T., & Dhar, S. U. (2013). Autism genetic testing: A qualitative study of awareness, attitudes, and experiences among parents of children with autism spectrum disorders. Genetics in Medicine, 15(4), 274–281. · DOI
- Condit, C. (2010). Public understandings of genetics and health. Clinical Genetics, 77(1), 1–9. · DOI
- Cooper, G. M., Coe, B. P., Girirajan, S., Rosenfeld, J. A., Vu, T. H., Baker, C., et al. (2011). A copy number variation morbidity map of developmental delay. Nature Genetics, 43, 838–846. · DOI · Paper page
- Coulter, M. E., Miller, D. T., Harris, D. J., Hawley, P., Picker, J., Roberts, A. E., & Irons, M. (2011). Chromosomal microarray testing influences medical management. Genetics in Medicine, 13(9), 770–776. · DOI
- Cuccaro, M. L., Czape, K., Alessandri, M., Lee, J., Deppen, A. R., Bendik, E., & Hahn, S. (2014). Genetic testing and corresponding services among individuals with autism spectrum disorder (ASD). American Journal of Medical Genetics Part A, 164(10), 2592–2600. · DOI
- Darilek, S., Ward, P., Pursley, A., Plunkett, K., Furman, P., Magoulas, P., & Eng, C. M. (2008). Pre-and postnatal genetic testing by array-comparative genomic hybridization: Genetic counseling perspectives. Genetics in Medicine, 10(1), 13–18. · DOI
- Dar-Nimrod, I., & Heine, S. J. (2011). Genetic essentialism: On the deceptive determinism of DNA. Psychological Bulletin, 137(5), 800. · DOI · Paper page
- Ellison, J. W., Ravnan, J. B., Rosenfeld, J. A., Morton, S. A., Neill, N. J., Williams, M. S., & Traylor, R. N. (2012). Clinical utility of chromosomal microarray analysis. Pediatrics, 130(5), e1085–e1095. · DOI · Paper page
- Eriksson, M. A., Westerlund, J., Hedvall, Å., Åmark, P., Gillberg, C., & Fernell, E. (2013). Medical conditions affect the outcome of early intervention in preschool children with autism spectrum disorders. European Child and Adolescent Psychiatry, 22(1), 23–33. · DOI
- Fanos, J. H. (2012). New “first families”: The psychosocial impact of new genetic technologies. Genetics in Medicine, 14(2), 189–190. · doi:10.1038/gim.2011.17
- Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570–574. · DOI · Paper page
- Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., & Ormond, K. E. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15, 565–574. · DOI · Paper page
- Grosse, S. D., & Khoury, M. J. (2006). What is the clinical utility of genetic testing? Genetics in Medicine, 8(7), 448–450. · DOI · Paper page
- Haga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. (2013). Public knowledge of and attitudes toward genetics and genetic testing. Genetic Testing and Molecular Biomarkers, 17(4), 327–335. · DOI · Paper page
- Hayeems, R. Z., Hoang, N., Chenier, S., Stavropoulos, D. J., Pu, S., Weksberg, R., & Shuman, C. (2014). Capturing the clinical utility of genomic testing: Medical recommendations following pediatric microarray. European Journal of Human Genetics. doi: 10.1038/ejhg.2014.260 . · DOI
- Hayward, D., Eikeseth, S., Gale, C., & Morgan, S. (2009). Assessing progress during treatment for young children with autism receiving intensive behavioural interventions. Autism : The International Journal of Research and Practice, 13(6), 613–633. doi: 10.1177/1362361309340029 . · DOI · Paper page
- Heil, K. M., & Schaaf, C. P. (2013). The genetics of autism spectrum disorders—A guide for clinicians. Current Psychiatry Reports, 15(1), 1–8.
- Kegley, J. (2003). An ethical imperative: Genetics education for physicians and patients. Medicine and Law, 22(2), 275–283.
- Khoury, M. J., McBride, C. M., Schully, S. D., Ioannidis, J. P., Feero, W. G., Janssens, A. C. J., & Cargill, M. (2010). The scientific foundation for personal genomics: Recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genetics in Medicine, 11(8), 559–567. · DOI · Paper page
- Lebowitz, M. S., Rosenthal, J. E., & Ahn, W. K. (2013). Effects of biological versus psychosocial explanations on stigmatization of children with ADHD. Journal of Attention Disorders. doi: 10.1177/1087054712469255 . · DOI
- Lenhard, W., Breitenbach, E., Ebert, H., Schindelhauer-Deutscher, H. J., & Henn, W. (2005). Psychological benefit of diagnostic certainty for mothers of children with disabilities: Lessons from down syndrome. American Journal of Medical Genetics, 133A(2), 170–175. doi: 10.1002/ajmg.a.30571 . · DOI
- Lipinski, S. E., Lipinski, M. J., Biesecker, L. G., & Biesecker, B. B. (2006). Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 142(4), 232–240. doi: 10.1002/ajmg.c.30107 . · DOI · Paper page
- Makela, N. L., Birch, P. H., Friedman, J. M., & Marra, C. A. (2009). Parental perceived value of a diagnosis for intellectual disability (ID): A qualitative comparison of families with and without a diagnosis for their child’s ID. American Journal of Medical Genetics. Part A, 149A(11), 2393–2402. doi: 10.1002/ajmg.a.33050 . · DOI
- Manning, M., & Hudgins, L. (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genetics in Medicine, 12(11), 742–745. doi: 10.1097/GIM.0b013e3181f8baad . · DOI · Paper page
- McMahon, W. M., Baty, B. J., & Botkin, J. R. (2006). Genetic counseling and ethical issues for autism. American Journal of Medical Genetics - Seminars in Medical Genetics, 142(1), 52–57. doi: 10.1002/ajmg.c.30082 . · DOI · Paper page
- Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook (2nd ed.). Thousand Oaks, CA: Sage.
- Miller, F. A., Hayeems, R. Z., & Bytautas, J. P. (2010b). What is a meaningful result? Disclosing the results of genomic research in autism to research participants. European Journal of Human Genetics, 18(8), 867–871. · DOI
- Narcisa, V., Discenza, M., Vaccari, E., Rosen-Sheidley, B., Hardan, A. Y., & Couchon, E. (2012). Parental interest in a genetic risk assessment test for autism spectrum disorders. Clinical Pediatrics, 52(2), 139–146. · DOI
- Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., & Hurles, M. E. (2006). Global variation in copy number in the human genome. Nature, 444(7118), 444–454. doi: 10.1038/nature05329 . · DOI · Paper page
- Regier, D., Friedman, J., Makela, N. L., Ryan, M., & Marra, C. (2009). Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: Willingness to pay from families of affected children. Clinical Genetics, 75(6), 514–521. · DOI
- Reiff, M., Bernhardt, B. A., Mulchandani, S., Soucier, D., Cornell, D., Pyeritz, R. E., & Spinner, N. B. (2012). “What does it mean?”: Uncertainties in understanding results of chromosomal microarray testing. Genetics in Medicine, 14(2), 250–258. · DOI
- Reiff, M., & Mulchandani, S. (2015). Integrating genetics into healthcare: Implications of genomic testing for individuals with autism spectrum disorders. In E. Giarelli, & K. Fisher (Eds.), Integrated healthcare for people with autism spectrum disorders: Interdisciplinary planning and delivery of care. Springfield, IL: Charles C. Thomas, Publishers, Ltd.
- Reiff, M., Ross, K., Mulchandani, S., Propert, K. J., Pyeritz, R. E., Spinner, N. B., & Bernhardt, B. A. (2013). Physicians’ perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clinical Genetics, 83(1), 23–30. · DOI
- Riggs, E. R., Wain, K. E., Riethmaier, D., Smith-Packard, B., Faucett, W., Hoppman, N., & Miller, D. T. (2014). Chromosomal microarray impacts clinical management. Clinical Genetics, 85(2), 147–153. · DOI · Paper page
- Roberts, J. L., Hovanes, K., Dasouki, M., Manzardo, A. M., & Butler, M. G. (2014). Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Gene, 535(1), 70–78. · DOI · Paper page
- Rosas-Blum, E., Shirsat, P., & Leiner, M. (2007). Communicating genetic information: A difficult challenge for future pediatricians. BMC Medical Education, 7(1), 17. · doi:10.1186/1472-6920-7-17
- Rossi, J., Newschaffer, C., & Yudell, M. (2013). Autism spectrum disorders, risk communication, and the problem of inadvertent harm. Kennedy Institute of Ethics Journal, 23(2), 105–138. · DOI
- Sasson, N. J., Lam, K., Parlier, M., Daniels, J. L., & Piven, J. (2013). Autism and the broad autism phenotype: Familial patterns and intergenerational transmission. Journal of Neurodevelopmental Disorders, 5(1), 11. · DOI · Paper page
- Scherer, S. W., & Dawson, G. (2011). Risk factors for autism: Translating genomic discoveries into diagnostics. Human Genetics, 130(1), 123–148. · DOI
- Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., & Miller, D. T. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), e727–e735. doi: 10.1542/peds.2009-1684 . · DOI · Paper page
- Shen, J., Lincoln, S., & Miller, D. T. (2014). Advances in Genetic Discovery and Implications for Counseling of Patients and Families with Autism Spectrum Disorders. Current Genetic Medicine Reports, 2(3), 124–134. · DOI
- Shen, J., & Miller, D. T. (2014). Advances in genetic diagnosis of autism spectrum disorders. Current Pediatrics Reports, 2(2), 71–81. · DOI
- Tabor, H. K., & Cho, M. K. (2007). Ethical implications of array comparative genomic hybridization in complex phenotypes: Points to consider in research. Genetics in Medicine, 9(9), 626–631. doi: 10.1097/GIM.0b013e3181485688 . · DOI
- Trottier, M., Roberts, W., Drmic, I., Scherer, S. W., Weksberg, R., Cytrynbaum, C., & Miller, F. A. (2013). Parents’ perspectives on participating in genetic research in autism. Journal of Autism and Developmental Disorders, 43(3), 556–568. · DOI
- Turbitt, E., Halliday, J., Amor, D., & Metcalfe, S. (2014). Preferences for results from genomic microarrays: Comparing parents and health care providers. Clinical Genetics, 87, 21–29. · DOI
- Veenstra-VanderWeele, J., Christian, S. L., & Cook, E. H. (2004). Autism as a paradigmatic complex genetic disorder. Annual Review of Genomics and Human Genetics, 5, 379–405. doi: 10.1146/annurev.genom.5.061903.180050 . · DOI · Paper page
- Yudell, M., Tabor, H. K., Dawson, G., Rossi, J., Newschaffer, C. J., & Working Group in Autism Risk Communication and Ethics. (2013). Priorities for autism spectrum disorder risk communication and ethics. Autism: The International Journal of Research and Practice, 17(6), 701–722. doi: 10.1177/1362361312453511 . · DOI
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Autism genetics: opportunities and challenges for clinical translation
Vorstman, J. A. S., Parr, J. R., Moreno-De-Luca, D., Anney, R. J. L., Nurnberger Jr, J. I., & Hallmayer, J. F. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.4 · Cited by 463
The Genetics of Autism Spectrum Disorders
Yuen, R. K. C., Szatmari, P., & Vorstman, J. A. S. (2019) · Autism and Pervasive Developmental Disorders · doi:10.1017/9781108297769.006 · Cited by 19
Quo Vadis clinical genomics of ASD?
Tammimies, K., Falck-Ytter, T., & Bölte, S. (2016) · Autism · doi:10.1177/1362361316635798 · Cited by 5
Metadata
- Authors
- Reiff, M., Giarelli, E., Bernhardt, B. A., Easley, E., Spinner, N. B., Sankar, P. L., & Mulchandani, S.
- Venue
- Journal of Autism and Developmental Disorders
- Published
- 2015-06-12
- Volume
- 45
- Issue
- 10
- Pages
- 3262-3275
- ISSN
- 0162-3257 (ISSN-L)
- 1573-3432
- OpenAlex
- W1956051203
- Cited by
- 81
- References
- 11
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
- Funders
- National Human Genome Research Institute of the National Institutes of Health (R21-HG-006560)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders. https://app.cochat.ai/papers/10.1007/s10803-015-2489-3
- The paper
- Reiff, M., Giarelli, E., Bernhardt, B. A., Easley, E., Spinner, N. B., Sankar, P. L., & Mulchandani, S. (2015). Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-015-2489-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.